Atopic Dermatitis (AD) Case Study

Click here for a PDF version of this case study

AD case study

Innovation in dermatology research icon


Innovaderm successfully managed this AD study
and this resulted in:

Enrollment completed 2 months earlier than planned;
Innovaderm CRU recruited 33% of patients


Study Characteristics

    • Study Phase: Ib
  • Patient Population: 36 subjects with moderate to severe AD
  • IP Route of Administration: Systemic - Oral
  • Site distribution: 10 sites in 2 countries (USA and Canada)
  • Study Design: Randomized, sequential, placebo-controlled, double-blind | Multiple ascending dose (MAD): 3 sequential cohorts
  • Study procedures: 4.5 mm punch skin biopsies, photographs, biomarker analysis, skin microbiome, pharmacokinetics, tape stripping and efficacy-safety assessments



Study Challenges

    • Recruitment during summer months; Seasonality impacts on AD flares
    • Short treatment duration; 4-week treatment period
    • Data and Safety Monitoring Board (DSMB) after each cohort; Challenging to manage without affecting recruitment



Key Success Factors & Strategies

Phone interview icon Recruitment completed in 6 months vs planned 8 months

Site engagement Outstanding contribution by Innovaderm's Clinical Research Unit



Recruitment Curve


Enrollment target reached 2 months ahead of schedule


Contact us


Get notified to have the latest trends and be at the forefront of dermatology clinical research and innovation.

Newsletter subscription resources

*By subscribing to our newsletter, you acknowledge and agree to the terms of our privacy policy.

Innovaderm Research Wave